Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNAdamaging chemotherapy agents and radiation. Duan Z, Andrews NP, Chen CZ, Fan M, et al. Oncol Rep 2020;43:318-327.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Duan Z, Andrews NP, Chen CZ, Fan M, et al. Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNAdamaging chemotherapy agents and radiation. Oncol Rep 2020;43:318-327.
PMID: 31789405